Literature DB >> 25556252

HIV infection Worsens Age-Associated Defects in Antibody Responses to Influenza Vaccine.

Varghese K George1, Suresh Pallikkuth1, Anita Parmigiani1, Maria Alcaide2, Margaret Fischl3, Kristopher L Arheart4, Savita Pahwa1.   

Abstract

BACKGROUND: Antibody responses to seasonal influenza vaccines are defective during older age and human immunodeficiency virus (HIV) infection. The effect of HIV on immune function in aging is relatively unknown.
METHODS: HIV-infected and HIV-uninfected young women (age, 19-54 years) and older women (age, >55 years) were evaluated for B-cell and T-cell responses before and 4 weeks after influenza vaccination.
RESULTS: Frequencies of seroprotection pre-vaccination and vaccine responsiveness (≥4-fold increase in antibody titer) were lower in HIV-infected participants than in age-matched HIV-uninfected participants. A subgroup of vaccine nonresponders were compared to responders and found to have reduced frequencies of memory B cells and antigen-specific antibody-secreting cells after vaccination. Frequencies of peripheral T-follicular helper (pTfh) cells correlated with memory B-cell function and influenza A(H1N1) antibody titers. Serologic and immunologic deficits were most frequent in older HIV-infected participants. Underlying CD4(+) T-cell immune activation and inflammation correlated negatively with antibody titers and B-cell function, which was not enhanced by exogenous interleukin 21 supplementation in HIV-infected, older vaccine nonresponders.
CONCLUSIONS: Immune activation associated with HIV infection and impaired pTfh function heighten deficiencies in antibody responses to influenza vaccine in older individuals. Strategies to reduce immune activation or augment pTfh function may enhance antibody responses in the aging HIV-infected population.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CD4 T-cell immune activation; HIV infection; IL-21; aging; inflammation; memory B cells; peripheral T follicular helper cells; seasonal influenza vaccination

Mesh:

Substances:

Year:  2015        PMID: 25556252      PMCID: PMC4836723          DOI: 10.1093/infdis/jiu840

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system.

Authors:  Shane Crotty; Rachael D Aubert; John Glidewell; Rafi Ahmed
Journal:  J Immunol Methods       Date:  2004-03       Impact factor: 2.303

Review 2.  Commentary: benefits of influenza vaccine in US elderly--new studies raise questions.

Authors:  W Paul Glezen; Lone Simonsen
Journal:  Int J Epidemiol       Date:  2005-12-20       Impact factor: 7.196

Review 3.  Interleukin-6 in aging and chronic disease: a magnificent pathway.

Authors:  Marcello Maggio; Jack M Guralnik; Dan L Longo; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-06       Impact factor: 6.053

4.  Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling.

Authors:  A P Cope; R S Liblau; X D Yang; M Congia; C Laudanna; R D Schreiber; L Probert; G Kollias; H O McDevitt
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

5.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface.

Authors:  P Isomäki; M Panesar; A Annenkov; J M Clark; B M Foxwell; Y Chernajovsky; A P Cope
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

7.  Compromised B cell responses to influenza vaccination in HIV-infected individuals.

Authors:  Angela Malaspina; Susan Moir; Susan M Orsega; Joshua Vasquez; Natalie J Miller; Eileen T Donoghue; Shyamasundaran Kottilil; Misrak Gezmu; Dean Follmann; Galina M Vodeiko; Roland A Levandowski; JoAnn M Mican; Anthony S Fauci
Journal:  J Infect Dis       Date:  2005-03-24       Impact factor: 5.226

Review 8.  Molecular programming of B cell memory.

Authors:  Michael McHeyzer-Williams; Shinji Okitsu; Nathaniel Wang; Louise McHeyzer-Williams
Journal:  Nat Rev Immunol       Date:  2011-12-09       Impact factor: 53.106

9.  Germinal center reaction: antigen affinity and presentation explain it all.

Authors:  Michael A Oropallo; Andrea Cerutti
Journal:  Trends Immunol       Date:  2014-06-13       Impact factor: 16.687

10.  Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults.

Authors:  Ramin Sedaghat Herati; Morgan A Reuter; Douglas V Dolfi; Kathleen D Mansfield; Htin Aung; Osama Z Badwan; Raj K Kurupati; Senthil Kannan; Hildegund Ertl; Kenneth E Schmader; Michael R Betts; David H Canaday; E John Wherry
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

View more
  38 in total

Review 1.  Tfh cell response in influenza vaccines in humans: what is visible and what is invisible.

Authors:  Hideki Ueno
Journal:  Curr Opin Immunol       Date:  2019-03-25       Impact factor: 7.486

Review 2.  CD4+ T Cell Differentiation in Chronic Viral Infections: The Tfh Perspective.

Authors:  Laura A Vella; Ramin S Herati; E John Wherry
Journal:  Trends Mol Med       Date:  2017-11-12       Impact factor: 11.951

3.  Impact of aging and HIV infection on serologic response to seasonal influenza vaccination.

Authors:  Suresh Pallikkuth; Lesley R De Armas; Rajendra Pahwa; Stefano Rinaldi; Varghese K George; Celeste M Sanchez; Li Pan; Gordon Dickinson; Allan Rodriguez; Margaret Fischl; Maria Alcaide; Savita Pahwa
Journal:  AIDS       Date:  2018-06-01       Impact factor: 4.177

4.  A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses.

Authors:  Suresh Pallikkuth; Sidhartha Chaudhury; Pinyi Lu; Li Pan; Erik Jongert; Ulrike Wille-Reece; Savita Pahwa
Journal:  Elife       Date:  2020-04-29       Impact factor: 8.140

5.  Implications of Immune Checkpoint Expression During Aging in HIV-Infected People on Antiretroviral Therapy.

Authors:  Lesley R de Armas; Suresh Pallikkuth; Stefano Rinaldi; Rajendra Pahwa; Savita Pahwa
Journal:  AIDS Res Hum Retroviruses       Date:  2019 Nov/Dec       Impact factor: 2.205

6.  Induction of IL21 in Peripheral T Follicular Helper Cells Is an Indicator of Influenza Vaccine Response in a Previously Vaccinated HIV-Infected Pediatric Cohort.

Authors:  Lesley R de Armas; Nicola Cotugno; Suresh Pallikkuth; Li Pan; Stefano Rinaldi; M Celeste Sanchez; Louis Gonzalez; Alberto Cagigi; Paolo Rossi; Paolo Palma; Savita Pahwa
Journal:  J Immunol       Date:  2017-01-27       Impact factor: 5.422

7.  Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination.

Authors:  Zhenwu Luo; Lei Ma; Lumin Zhang; Lisa Martin; Zhuang Wan; Stephanie Warth; Andrew Kilby; Yong Gao; Pallavi Bhargava; Zhen Li; Hao Wu; Eric G Meissner; Zihai Li; J Michael Kilby; Guoyang Liao; Wei Jiang
Journal:  Vaccine       Date:  2015-12-22       Impact factor: 3.641

8.  The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.

Authors:  Anna M Powell; Zhenwu Luo; Lisa Martin; Zhuang Wan; Lei Ma; Guoyang Liao; Yuxia Song; Xiaochun Li; J Michael Kilby; Lei Huang; Wei Jiang
Journal:  Vaccine       Date:  2016-12-22       Impact factor: 3.641

Review 9.  Peripheral follicular helper T cells in acute viral diseases: a perspective on dengue.

Authors:  Luis A Sánchez-Vargas; Anuja Mathew
Journal:  Future Virol       Date:  2019-03-06       Impact factor: 1.831

10.  Reevaluation of immune activation in the era of cART and an aging HIV-infected population.

Authors:  Lesley R de Armas; Suresh Pallikkuth; Varghese George; Stefano Rinaldi; Rajendra Pahwa; Kristopher L Arheart; Savita Pahwa
Journal:  JCI Insight       Date:  2017-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.